Patent No. EP4233846 (titled "Pharmaceutical Formulations") was filed by Gilead Sciences on Jun 29, 2016. The application was issued on Dec 4, 2024.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| ELKINGTON AND FIFE | Sep 4, 2025 | ELKINGTON AND FIFE |
| EIP | Sep 3, 2025 | EIP |
| HAMM & WITTKOPP | Sep 2, 2025 | HAMM & WITTKOPP |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Mar 17, 2026
Dec 17, 2025
Dec 17, 2025
Dec 17, 2025
Dec 17, 2025
Dec 12, 2025
Dec 12, 2025
Dec 12, 2025
Sep 17, 2025
Sep 17, 2025
Sep 17, 2025
Sep 17, 2025
Sep 9, 2025
Sep 8, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 4, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 3, 2025
Sep 2, 2025
Sep 2, 2025
Sep 2, 2025
Sep 2, 2025
Sep 2, 2025
Sep 2, 2025
Sep 2, 2025
Sep 2, 2025
Sep 2, 2025
Sep 2, 2025
Dec 17, 2024
Nov 7, 2024
Oct 24, 2024
Oct 24, 2024
Oct 24, 2024
Oct 24, 2024
Oct 24, 2024
Oct 7, 2024
Oct 7, 2024
Oct 2, 2024
Oct 2, 2024
Oct 2, 2024
Oct 2, 2024
Oct 2, 2024
Oct 1, 2024
Oct 1, 2024
Oct 1, 2024
Oct 1, 2024
Oct 1, 2024
Sep 24, 2024
Sep 24, 2024
Sep 24, 2024
Sep 24, 2024
Sep 24, 2024
Aug 29, 2024
Aug 29, 2024
Aug 29, 2024
Aug 29, 2024
Aug 29, 2024
Aug 29, 2024
Jul 30, 2024
Apr 4, 2024
Apr 4, 2024
Apr 4, 2024
Apr 4, 2024
Apr 4, 2024
Apr 4, 2024
Oct 9, 2023
Sep 5, 2023
Aug 31, 2023
Aug 31, 2023
Aug 31, 2023
Aug 31, 2023
Aug 17, 2023
Aug 2, 2023
Jun 8, 2023
Jun 8, 2023
Jun 8, 2023
Jun 8, 2023
Mar 29, 2023
Mar 20, 2023
Mar 20, 2023
Mar 20, 2023
Mar 20, 2023
Mar 20, 2023
Mar 20, 2023
Mar 20, 2023
Jan 23, 2017
Jan 23, 2017
Jan 23, 2017
Jan 23, 2017